US Patent 8703700 Bimacrocylic HCV NS3 protease inhibitors
Patent 8703700 was granted and assigned to Sequoia Pharmaceuticals on April, 2014 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8703700 Bimacrocylic HCV NS3 protease inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.